We are live on ! Find out more
RNTX

Rein Therapeutics
RNTX

37 hedge funds and large institutions have $8.34M invested in Rein Therapeutics in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.01% less ownership

Funds ownership: 1.78% → 1.77% (-0.01%)

12% less funds holding

Funds holding: 42 → 37 (-5)

49% less capital invested

Capital invested by funds: $16.5M → $8.34M (-$8.16M)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
37
Holders Change
-5
Holders Change %
-11.9%
% of All Funds
0.62%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
10
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
William Blair & Company
William Blair & Company
Illinois
+$65.2K
2
TSS
Two Sigma Securities
New York
+$34.5K
3
Renaissance Technologies
Renaissance Technologies
New York
+$26K
4
Jane Street
Jane Street
New York
+$18.8K
5
State Street
State Street
Massachusetts
+$14.2K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$87.4K
2
B
Bailard
California
-$66K
3
JSMC
Jess S. Morgan & Co
California
-$51K
4
Citigroup
Citigroup
New York
-$15K
5
KWM
Keebeck Wealth Management
Illinois
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cetera Investment Advisers
26
Cetera Investment Advisers
Illinois
$5K – – –
LSAG
27
Lake Street Advisors Group
New Hampshire
$5K – – –
Mercer Global Advisors
28
Mercer Global Advisors
Colorado
$5K – – –
KPW
29
Kore Private Wealth
New York
$3K – – –
LPL Financial
30
LPL Financial
California
$3K – – –
RWP
31
Ridgecrest Wealth Partners
California
$3K – – –
BlackRock
32
BlackRock
New York
$1K -$87.4K -9,520 -98%
UBS Group
33
UBS Group
Switzerland
$1K -$4.19K -456 -82%
Bank of America
34
Bank of America
North Carolina
$1K -$1.84K -200 -52%
B
35
Bailard
California
– -$66K -6,401 Closed
JSMC
36
Jess S. Morgan & Co
California
– -$51K -5,000 Closed
Citigroup
37
Citigroup
New York
– -$15K -1,506 Closed
KWM
38
Keebeck Wealth Management
Illinois
– -$14K -1,350 Closed
KA
39
Kovack Advisors
Florida
– -$7K -750 Closed
HighTower Advisors
40
HighTower Advisors
Illinois
– -$6K -600 Closed
JP Morgan Chase
41
JP Morgan Chase
New York
– -$1K -55 Closed
Wells Fargo
42
Wells Fargo
California
– +$18 +2 +10%
1
2

RNTX Hedge Fund Activity: Q2 2022 in Review

37 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Rein Therapeutics (RNTX) for Q2 2022, worth a combined $8.34M — down 49% from $16.5M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of RNTX and 2 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 10 added.

The largest buyer was William Blair & Company, adding an estimated $65.2K. The largest seller was BlackRock, cutting an estimated $87.4K.

  • 37 institutional investors held Rein Therapeutics (RNTX) as of Q2 2022, down from 42 in Q1 2022.
  • Funds reported $8.34M of Rein Therapeutics stock for Q2 2022, down 49% quarter-over-quarter.
  • 2 funds opened new Rein Therapeutics positions in Q2 2022 and 7 closed out, a net change of -5 holders.
  • The largest Rein Therapeutics buyer in Q2 2022 was William Blair & Company, an estimated $65.2K added.
  • The largest Rein Therapeutics seller in Q2 2022 was BlackRock, an estimated $87.4K sold.

Based on aggregated 13F filings for Q2 2022.